Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis

Kidney Int. 2004 Dec;66(6):2181-92. doi: 10.1111/j.1523-1755.2004.66008.x.

Abstract

Background: The intrarenal renin-angiotensin system (RAS) is intimately involved in the tubular cell proliferation, apoptosis and regeneration that occur following renal injury. Though tubular angiotensin II (Ang II) type 2 receptors (AT2R) decrease greatly after birth, their number increases after injury. Notably, during recovery from injury, renal tubular cells display a relatively immature phenotype expressing genes that are involved in nephron development, for example, the paired homeobox-2 gene (Pax-2). The present investigation hypothesized that AT2R activation would stimulate Pax-2 gene expression in immortalized rat renal proximal tubular cells (IRPTC), as we have found in fetal cells.

Methods: Pax-2 gene expression in IRPTC was evaluated by immunofluorescence, Western blot, reverse transcription-polymerase chain reaction (RT-PCR) with or without Ang II treatment; apoptosis and proliferation were analyzed by terminal transferase-mediated deoxyuridine triphosphate (dUTP) nick end-labeling (TUNEL) assay and bromodeoxyuridine (BrdU) incorporation in stable IRPTC transformants with Pax-2 sense and antisense orientation, respectively.

Results: Ang II up-regulated Pax-2 gene expression via AT2R in IRPTC. The stimulatory effect of both Ang II on Pax-2 gene expression was blocked by PD123319 (AT2R inhibitor), AG 490 (specific Janus kinase 2 (JAK2) inhibitor) and genistein (tyrosine kinase inhibitor), but not by losartan (AT1R inhibitor). Stable transfection of sense Pax-2 cDNA increased, whereas antisense Pax-2 cDNA down-regulated Pax-2 expression.

Conclusion: Our studies suggest that Ang II stimulates Pax-2 gene expression in IRPTC via AT2R and the JAK2/signal transducers and activators of transcription (STAT) signaling transduction pathway, which may be important in renal repair following injury. Cells lacking Pax-2 gene expression appear to be prone toward apoptosis rather than proliferation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin II / pharmacology*
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Cell Division / drug effects
  • Cell Division / physiology
  • Cells, Cultured
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Fluorescent Antibody Technique
  • Gene Expression / drug effects
  • Gene Expression / physiology
  • Genistein / pharmacology
  • Imidazoles / pharmacology
  • Janus Kinase 2
  • Kidney Tubules, Proximal / cytology*
  • Kidney Tubules, Proximal / drug effects*
  • Kidney Tubules, Proximal / metabolism
  • PAX2 Transcription Factor
  • Phosphorylation / drug effects
  • Protein-Tyrosine Kinases / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Pyridines / pharmacology
  • Rats
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Transcription Factors / genetics*
  • Transcription Factors / metabolism
  • Transformation, Genetic
  • Tyrphostins / pharmacology
  • Up-Regulation / drug effects
  • Up-Regulation / physiology
  • Vasoconstrictor Agents / pharmacology*

Substances

  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Imidazoles
  • PAX2 Transcription Factor
  • Proto-Oncogene Proteins
  • Pyridines
  • Transcription Factors
  • Tyrphostins
  • Vasoconstrictor Agents
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Angiotensin II
  • PD 123319
  • Genistein
  • Protein-Tyrosine Kinases
  • Jak2 protein, rat
  • Janus Kinase 2